Evidence map›Paper›PMID 26026485›Full record

Trial reportRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2015

IAEA randomised trial of optimal single dose radiotherapy in the treatment of painful bone metastases.

Peter Hoskin, Ana Rojas, Elena Fidarova, Rakesh Jalali, Ana Mena Merino, Adela Poitevin, Seam Oucrif, Sherif Abdelwahab, Lotfi Kochbati, Aista Plieskiene and 4 more

Abstract readClinical Trial, Phase IIIRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Sustainability in German radiotherapy: professionals' perspectives on energy savings-results of a DEGRO working group survey.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  5. Article
  6. Article
  7. [Comparison of different fraction doses in single dose irradiation of painful bone metastases].Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Peter HoskinCancer Centre, Mount Vernon Hospital, UK.
Ana RojasCancer Centre, Mount Vernon Hospital, UK. Electronic address: arc03@btconnect.com.
Elena FidarovaIAEA, Division of Human Health, Vienna, Austria.
Rakesh JalaliTata Memorial Hospital, Mumbai, India.
Ana Mena MerinoHospital Son Dureta, Palmas de Mallorca, Spain.
Adela PoitevinInstituto Nacional Cancerología, México DF, Mexico.
Seam OucrifDep. Radiothérapie, Centre Hospitalier Universitaire, Alger, Algeria.
Sherif AbdelwahabMisr Oncology Centre, Cairo, Egypt.
Lotfi KochbatiRadiotherapie carcinologique, Institut Salah Azaiz, Tunis, Tunisia.
Aista PlieskieneInstitute of Oncology, Vilnius University, Lithuania.
Francesc CasasRadiation Oncology, Hospital Clínic i Universitari, Barcelona, Spain.
Susana StojanovicInstitute of Oncology & Radiology, Belgrade, Serbia.
Günther SchneiderFundacao Faculdade Federal de Ciencias Medicas, Porto Alegre, Brazil.
Branislav JeremicIAEA, Division of Human Health, Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo determine the optimal single-dose radiotherapy schedule for pain from bone metastases in a multi-centre, international, randomised trial. PATIENTS AND

methods651 patients were randomised to either 8Gy (n=325) or 4Gy (n=326) radiotherapy. Pain at 4, 8, 12, 24 and 52weeks was assessed using a Categorical Scale (CS) and a Visual Analogue Scale (VAS). The primary endpoint was response at 4weeks.

resultsThere was no significant difference in patient demographics and other co-variates. The complete response (CR) rate and ORR (complete or partial response) for all follow-up times were higher after 8Gy (p=0.02). The Kaplan-Meier actuarial rate (categorical scale) at 4weeks for ORR was 80% after 8Gy compared to 68% after 4Gy (p=0.0015). 117 re-treatments were given of which 72 were in the 4Gy group and 45 in 8Gy arm (p=0.01).

conclusionsThere was a marked consistent difference in pain relief at all time points in favour of 8Gy. These data reinforce the case for single dose 8Gy radiotherapy to be recommended for metastatic bone pain in all healthcare settings.

Indexed as

AdultAgedAged, 80 and overBone NeoplasmsHumansMiddle AgedPainPain ManagementPain MeasurementRadiotherapy DosageBone metastasesBone painDose responsePalliative radiotherapy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.